A systematic review of purine analogs revealed heterogeneity between trials in treatment effects on response and progression free survival, but not survival, perhaps partly due to variations in analytical methods. In addition, combination treatments required evaluation. Therefore, individual patient data were sought for all randomized trials in untreated chronic lymphocytic leukemia which involved a purine analog, but which did not include antibody therapies. Sixteen trials were found, addres...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials.
If you are the owner of this record, you can report an update to it here: Report update to this record